GlassScriptPhysician profile
Melinda Beth Allen
NPI 1609280882
$2,951.76
in general payments reported to CMS, 2019-2025
16 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $669 · 2022: $997 · 2023: $434 · 2024: $502 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,285.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $785.01 | 2021-2025 | Ingrezza |
| Abbvie INC. | $658.18 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $364.43 | 2021-2022 | |
| Alkermes, INC. | $323.40 | 2022-2025 | Lybalvi, Aristada |
| Lundbeck LLC | $274.38 | 2023-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $146.58 | 2024-2025 | Fanapt |
| Sunovion Pharmaceuticals INC. | $121.23 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $88.28 | 2022-2024 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $65.68 | 2023-2024 | Austedo, Uzedy, Austedo Xr |
| Axsome Therapeutics, INC. | $27.58 | 2024 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $22.66 | 2023 | Trintellix |
| Philips North America LLC | $18.22 | 2023 | |
| Bioxcel Therapeutics, INC. | $17.74 | 2023 | Igalmi |
| Sage Therapeutics, LLC | $14.02 | 2024 | |
| Corium, LLC | $12.45 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melinda Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.